These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 7678279

  • 1. Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120.
    Gorny MK, Xu JY, Karwowska S, Buchbinder A, Zolla-Pazner S.
    J Immunol; 1993 Jan 15; 150(2):635-43. PubMed ID: 7678279
    [Abstract] [Full Text] [Related]

  • 2. Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivity.
    Gorny MK, VanCott TC, Hioe C, Israel ZR, Michael NL, Conley AJ, Williams C, Kessler JA, Chigurupati P, Burda S, Zolla-Pazner S.
    J Immunol; 1997 Nov 15; 159(10):5114-22. PubMed ID: 9366441
    [Abstract] [Full Text] [Related]

  • 3. Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides.
    Haynes BF, Torres JV, Langlois AJ, Bolognesi DP, Gardner MB, Palker TJ, Scearce RM, Jones DM, Moody MA, McDanal C.
    J Immunol; 1993 Aug 01; 151(3):1646-53. PubMed ID: 8335949
    [Abstract] [Full Text] [Related]

  • 4. Permissive residues within the minimal epitopes of neutralizing monoclonal antibodies to the V3 loop of HIV-1.
    Laisney IL, Benjamin H, Gefter M, Strosberg AD.
    Eur J Immunol; 1996 Jul 01; 26(7):1634-40. PubMed ID: 8766572
    [Abstract] [Full Text] [Related]

  • 5. Dual specificity of a monoclonal anti-idiotypic antibody for HIV-1 neutralizing monoclonals 110.3 and 110.4 as well as the V3 loop of gp120.
    Connelly RJ, Kahn M, Blake J, Haffar OK, Thomas EK.
    Virology; 1994 Dec 01; 205(2):554-7. PubMed ID: 7526543
    [Abstract] [Full Text] [Related]

  • 6. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K, Durani V, Miranda ER, Citron M, Liang X, Schleif W, Joyce JG, Varadarajan R.
    Biochem J; 2006 Nov 01; 399(3):483-91. PubMed ID: 16827663
    [Abstract] [Full Text] [Related]

  • 7. Dissociation rate of antibody-gp120 binding interactions is predictive of V3-mediated neutralization of HIV-1.
    VanCott TC, Bethke FR, Polonis VR, Gorny MK, Zolla-Pazner S, Redfield RR, Birx DL.
    J Immunol; 1994 Jul 01; 153(1):449-59. PubMed ID: 7515931
    [Abstract] [Full Text] [Related]

  • 8. The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1.
    Zolla-Pazner S, Zhong P, Revesz K, Volsky B, Williams C, Nyambi P, Gorny MK.
    AIDS Res Hum Retroviruses; 2004 Nov 01; 20(11):1254-8. PubMed ID: 15588347
    [Abstract] [Full Text] [Related]

  • 9. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
    Rosen O, Chill J, Sharon M, Kessler N, Mester B, Zolla-Pazner S, Anglister J.
    Biochemistry; 2005 May 17; 44(19):7250-8. PubMed ID: 15882063
    [Abstract] [Full Text] [Related]

  • 10. Identification of a new neutralizing epitope conformationally affected by the attachment of CD4 to gp120.
    Kang CY, Hariharan K, Posner MR, Nara P.
    J Immunol; 1993 Jul 01; 151(1):449-57. PubMed ID: 7686944
    [Abstract] [Full Text] [Related]

  • 11. Two major groups of neutralizing anti-gp120 antibodies exist in HIV-infected individuals. Evidence for epitope diversity around the CD4 attachment site.
    Chamat S, Nara P, Berquist L, Whalley A, Morrow WJ, Köhler H, Kang CY.
    J Immunol; 1992 Jul 15; 149(2):649-54. PubMed ID: 1378074
    [Abstract] [Full Text] [Related]

  • 12. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L, Zolla-Pazner S, Gorny MK, Cheng-Mayer C.
    Virology; 1997 Mar 17; 229(2):360-9. PubMed ID: 9126249
    [Abstract] [Full Text] [Related]

  • 13. Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.
    Laman JD, Schellekens MM, Abacioglu YH, Lewis GK, Tersmette M, Fouchier RA, Langedijk JP, Claassen E, Boersma WJ.
    J Virol; 1992 Mar 17; 66(3):1823-31. PubMed ID: 1637373
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 GP120 induces HIV-1 neutralizing antibodies in rabbits.
    Fung MS, Sun CR, Liou RS, Gordon W, Chang NT, Chang TW, Sun NC.
    J Immunol; 1990 Oct 01; 145(7):2199-206. PubMed ID: 2398276
    [Abstract] [Full Text] [Related]

  • 18. Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity.
    Thompson J, Pope T, Tung JS, Chan C, Hollis G, Mark G, Johnson KS.
    J Mol Biol; 1996 Feb 16; 256(1):77-88. PubMed ID: 8609615
    [Abstract] [Full Text] [Related]

  • 19. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC, Stuber G, Wagner R, Wolf H, Modrow S.
    J Pept Sci; 1995 Feb 16; 1(2):109-23. PubMed ID: 9222988
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.